150 related articles for article (PubMed ID: 8787218)
1. Pathogenesis and therapy of amyotrophic lateral sclerosis. Introduction.
Serratrice GT; Munsat TL
Adv Neurol; 1995; 68():xix-xx. PubMed ID: 8787218
[No Abstract] [Full Text] [Related]
2. [Neurotrophic factor treatment in amyotrophic lateral sclerosis].
Tsuzaka K; Mitsumoto H
No To Shinkei; 1998 Jul; 50(7):625-30. PubMed ID: 9739520
[No Abstract] [Full Text] [Related]
3. Use of growth factors in the treatment of motor neuron diseases.
Windebank AJ
Adv Neurol; 1995; 68():229-34. PubMed ID: 8787234
[No Abstract] [Full Text] [Related]
4. Neurotrophic factors and amyotrophic lateral sclerosis.
Askanas V
Adv Neurol; 1995; 68():241-4. PubMed ID: 8787236
[No Abstract] [Full Text] [Related]
5. Will ciliary neurotrophic factor slow progression of motor neuron disease?
Longo FM
Ann Neurol; 1994 Aug; 36(2):125-7. PubMed ID: 8053646
[No Abstract] [Full Text] [Related]
6. Genetic variation in the ciliary neurotrophic factor receptor alpha gene and familial amyotrophic lateral sclerosis.
Imura T; Shimohama S; Kawamata J; Kimura J
Ann Neurol; 1998 Feb; 43(2):275. PubMed ID: 9485075
[No Abstract] [Full Text] [Related]
7. New hope for treatment of Lou Gehrig's disease.
Piascik P
J Am Pharm Assoc (Wash); 1996 Jun; NS36(6):355-6. PubMed ID: 8697260
[No Abstract] [Full Text] [Related]
8. Overview of the pathogenesis and therapy of amyotrophic lateral sclerosis.
Serratrice GT; Munsat TL
Adv Neurol; 1995; 68():1-5. PubMed ID: 8787219
[No Abstract] [Full Text] [Related]
9. [Brain-derived growth factor: current aspects].
Serrano-Sánchez T; Díaz-Armesto I
Rev Neurol; 1998 Jun; 26(154):1027-32. PubMed ID: 9658488
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group.
Miller RG; Petajan JH; Bryan WW; Armon C; Barohn RJ; Goodpasture JC; Hoagland RJ; Parry GJ; Ross MA; Stromatt SC
Ann Neurol; 1996 Feb; 39(2):256-60. PubMed ID: 8967757
[TBL] [Abstract][Full Text] [Related]
11. [ALS and neurotrophic factors--HGF as a novel neurotrophic and neuroregenerative factor].
Funakoshi H; Ohya W; Kadoyama K; Nakamura T
Brain Nerve; 2007 Oct; 59(10):1195-202. PubMed ID: 17969361
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials in amyotrophic lateral sclerosis: the tenuous past and the promising future.
Choudry RB; Cudkowicz ME
J Clin Pharmacol; 2005 Dec; 45(12):1334-44. PubMed ID: 16291708
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal delivery of BDNF.
Schluep M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):141. PubMed ID: 11464948
[No Abstract] [Full Text] [Related]
14. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
15. [Amyotrophic lateral sclerosis].
Moriwaka F
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
[TBL] [Abstract][Full Text] [Related]
16. Rat brain mast cells: an in vitro paradigm for assessing the toxic effects of neurotropic therapeutics.
Purcell WM; Westgate C; Atterwill CK
Neurotoxicology; 1996; 17(3-4):845-50. PubMed ID: 9086508
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis and therapeutic perspectives for amyotrophic lateral sclerosis (ALS)].
Abe K
Rinsho Shinkeigaku; 2007 Nov; 47(11):790-4. PubMed ID: 18210800
[TBL] [Abstract][Full Text] [Related]
18. [Neurotrophic factors and amyotrophic lateral sclerosis (ALS)--therapeutic potential of a new neurotrophic factor: HGF in ALS].
Funakoshi H; Nakamura T
No To Shinkei; 2003 Oct; 55(10):841-5. PubMed ID: 14635512
[No Abstract] [Full Text] [Related]
19. USAN Council. List No.431. New names. Abrineurin.
Clin Pharmacol Ther; 2000 Oct; 68(4):456. PubMed ID: 11184473
[No Abstract] [Full Text] [Related]
20. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
Al-Chalabi A; Scheffler MD; Smith BN; Parton MJ; Cudkowicz ME; Andersen PM; Hayden DL; Hansen VK; Turner MR; Shaw CE; Leigh PN; Brown RH
Ann Neurol; 2003 Jul; 54(1):130-4. PubMed ID: 12838531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
